These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14040098)

  • 1. A study of Clostridium botulinum toxoid. II. Type B toxoid.
    VOROB'EV AA; VASIL'EV NN; ENICHEV VM; PATRIKEYEV GT; SHEVELEV VM; ZYBIN VD; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1851-6. PubMed ID: 14040098
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 3. [STUDY OF BOTULINUM TOXOIDS. VI. TYPE D BOTULINUM TOXOID].
    VOROBEV AA; VASILEV NN; SHEVELEV VM; VORONOVA ZA; PETROVA EK; BAZHENOVA GA; ANDROSHCHUK SM
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():87-92. PubMed ID: 14119975
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of Clostridium botulinum toxoids. I. Type A Clostridium botulinum toxoid.
    VOROB'EV AA; VASIL'EV NN; PATRIKEYEV GT; ZYBIN VD; SHMELEV VM; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1601-8. PubMed ID: 14040099
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE EFFECT OF PRELIMINARY ADMINISTRATION OF TOXOID ON THE RESISTANCE OF MICE TO BOTULINUM TOXIN. (PRELIMINARY REPORT)].
    ZHUK LN
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jul; 41():39-42. PubMed ID: 14247222
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on immunity to toxins of Clostridium botulinum. VII. Purification and detoxification of trypsin-activated type E toxin.
    FIOCK MA; YARINSKY A; DUFF JT
    J Bacteriol; 1961 Jul; 82(1):66-71. PubMed ID: 13699727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on immunity to toxins of Clostridium botulinum. II. Production and purification of type B toxin for toxoid.
    DUFF JT; KLERER J; BIBLER RH; MOORE DE; GOTTFRIED C; WRIGHT GG
    J Bacteriol; 1957 May; 73(5):597-601. PubMed ID: 13428702
    [No Abstract]   [Full Text] [Related]  

  • 9. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on immunity to toxins of Clostridium botulinum. IV. Production and purification of type C toxin for conversion to toxoid.
    CARDELLA MA; DUFF JT; GOTTFRIED C; BEGEL JS
    J Bacteriol; 1958 Mar; 75(3):360-5. PubMed ID: 13513612
    [No Abstract]   [Full Text] [Related]  

  • 11. Adsorption of type A and B Clostridium botulinum toxoids of varying degrees of purification on aluminium hydroxide.
    VOROB'EV AA; VASIL'EV NN
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1076-81. PubMed ID: 14040100
    [No Abstract]   [Full Text] [Related]  

  • 12. SPECIFIC PRECOCIOUS PROTECTIVE ACTION OF TOXOIDS.
    MELLANBY J; VANHEYNINGEN WE
    Nature; 1964 Jul; 203():312-3. PubMed ID: 14201781
    [No Abstract]   [Full Text] [Related]  

  • 13. Field evaluation of Clostridium botulinum type C toxoids in mink.
    APPLETON GS; WHITE PG
    Am J Vet Res; 1959 Jan; 20():166-9. PubMed ID: 13793981
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphological and histochemical changes during the immunization of guinea-pigs with Clostridium oedematiens toxoid.
    YERMAN BA
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1272-6. PubMed ID: 14040375
    [No Abstract]   [Full Text] [Related]  

  • 15. Clostridium botulinum type E toxin and toxoid.
    BARRON AL; REED GB
    Can J Microbiol; 1954 Oct; 1(2):108-17. PubMed ID: 14352045
    [No Abstract]   [Full Text] [Related]  

  • 16. [CL. botulinum F. II. Biochemical properties. A study of toxin and toxoid formation].
    Mikhaĭlova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Oct; 42(10):39-43. PubMed ID: 5332637
    [No Abstract]   [Full Text] [Related]  

  • 17. The partial reactivation of formalin-inactivated Clostridium botulinum type C toxin.
    MARTY EW
    Am J Vet Res; 1961 Jul; 22():770-4. PubMed ID: 13767602
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDIES ON CLOSTRIDIUM BOTULINUM E. II. CULTURE MEDIA FROM TOXIN PRODUCTION].
    MEISEL H; ALBRYCHT H; RYMKIEWICZ D; SWITALSKA A; TREMOWLER P
    Med Dosw Mikrobiol; 1964; 16():201-6. PubMed ID: 14198035
    [No Abstract]   [Full Text] [Related]  

  • 19. PREPARATION AND ASSAY OF THE INTERNATIONAL STANDARDS FOR CLOSTRIDIUM BOTULINUM TYPES A, B, C, D AND E ANTITOXINS.
    BOWMER EJ
    Bull World Health Organ; 1963; 29(6):701-9. PubMed ID: 14107742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of botulinum toxoids. V. Botulinum tritoxoids of types A, B and C].
    VOROB'EV AA; LABINSKII AP
    Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():91-5. PubMed ID: 13926745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.